Pacer Advisors
ARRY

Pacer Advisors’s Array Biopharma Inc ARRY Stock Holding History

Pacer Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17,639
Closed -$268K – 1175
2018
Q3 		$268K Buy
+17,639
New +$270K 0.01% 972
2018
Q1 		– Sell
-6,050
Closed -$77K – 1181
2017
Q4 		$77K Buy
+6,050
New +$68.8K 0.01% 983

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Pacer Advisors's ARRY Position: Q4 2018 in Review

Pacer Advisors sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 17,639 shares — an estimated $268K sold.

Pacer Advisors first reported a position in ARRY in Q4 2017 and held it in 2 quarters. The position peaked at $268K in Q3 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

  • Pacer Advisors reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
  • Pacer Advisors sold 17,639 Array Biopharma Inc shares in Q4 2018, an estimated $268K.
  • Pacer Advisors first reported a position in Array Biopharma Inc in Q4 2017 and held it in 2 quarters.
  • Pacer Advisors's Array Biopharma Inc position peaked at $268K in Q3 2018.
  • 236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Pacer Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.